Overview
Yoshikazu Hirano practices practicing medicine in Tokyo, Japan.
Mr. Hirano is highly rated in 1 condition, according to our data. His clinical expertise encompasses Retrograde Ejaculation, Urothelial Cancer, and Lithotripsy.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yoshikazu Hirano
Is Yoshikazu Hirano a top-rated expert for Lithotripsy?
MediFind is an objective health platform that identifies experts based on real-world data. Yoshikazu Hirano is classified as an Advanced expert for Lithotripsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yoshikazu Hirano participate in research or clinical trials?
Yes. Yoshikazu Hirano has published 9 articles and abstracts on conditions like Lithotripsy. You can view a list of Yoshikazu Hirano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- LithotripsyMr. Hirano isAdvanced. Learn about Lithotripsy.
- Experienced
- Retrograde EjaculationMr. Hirano isExperienced. Learn about Retrograde Ejaculation.
- Urothelial CancerMr. Hirano isExperienced. Learn about Urothelial Cancer.